LSBCF (LakeShore Biopharma Co) Other Financing: $39.46 Mil (TTM As of Mar. 2025)


What is LakeShore Biopharma Co Other Financing?

LakeShore Biopharma Co LSBCF Other Financing is $39.46 Mil as of Mar. 2025. The stock has 5 warning signs investors should review.

LakeShore Biopharma Co's Other Financing for the six months ended in Mar. 2025 was $0.00 Mil.

LakeShore Biopharma Co's Other Financing for the trailing twelve months (TTM) ended in Mar. 2025 was $39.46 Mil.

LakeShore Biopharma Co Other Financing Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Other Financing Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Other Financing
0.00 0.00 31.43 0.00 0.00

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Other Financing Get a 7-Day Free Trial Premium Member Only 31.43 0.00 39.46 0.00 0.00

LakeShore Biopharma Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $39.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $39.46 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Other Financing of $39.46 Mil as of Mar. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Other Financing too high?
LakeShore Biopharma Co's current Other Financing is $39.46 Mil.
How does LakeShore Biopharma Co's Other Financing compare to ACUT and PPCB?
LakeShore Biopharma Co's Other Financing of $39.46 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Other Financing is $39.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Other Financing of $39.46 Mil. The current Other Financing is $39.46 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Other Financing is $39.46 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.